A Study of Nivolumab or Placebo in Combination With Docetaxel in Men With Advanced Castration-resistant Prostate Cancer
Clinical trial NCT04100018 · COMPLETED
Trial details
- NCT number
- NCT04100018
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-06
- Primary completion
- 2023-06-01
- Enrollment
- 1030
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.